How many drugs treat Cachexia due to HIV?

Drug Landscape tracks 2 marketed treatments for Cachexia due to HIV (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/cachexia-due-to-hiv.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Cachexia due to HIV — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cachexia due to HIV (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Cachexia due to HIV, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Megace	MEGESTROL ACETATE	Bristol-Myers Squibb	Progestin	Glucocorticoid receptor		1971-01-01
megestrol	megestrol	National Center for Research Resources (NCRR)		Cytochrome P450 2C9, Multidrug resistance protein 1, Glucocorticoid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Bristol-Myers Squibb · 1 drug in Cachexia due to HIV
National Center for Research Resources (NCRR) · 1 drug in Cachexia due to HIV

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Cachexia due to HIV:

Cite this brief

Drug Landscape (2026). Cachexia due to HIV — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/cachexia-due-to-hiv. Accessed 2026-06-10.

Cachexia due to HIV full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing